文献速递瓣膜外科冠心病外科

主动脉瓣置换联合冠脉搭桥的瓣膜选择

Prosthesis Selection for Aortic Valve Replacement With Concomitant Coronary Artery Bypass Grafting.
PubMed 文献 · Ann Thorac Surg · 2021-03-02

该回顾性队列纳入2002至2018年湖北医院2485例50至69岁行主动脉瓣置换联合冠脉搭桥患者,倾向评分匹配后比较生物瓣与机械瓣各346对。两组生存、卒中及总再手术率无差异,生物瓣因瓣膜失功再手术风险更高,机械瓣大出血风险更高。

要点

  • 生物瓣因瓣膜失功再手术风险高于机械瓣(HR 2.72)。
  • 机械瓣大出血风险高于生物瓣(HR 1.92)。
  • 两组生存、卒中及总再手术率无差异。

核心结论

  • 两组长期生存、总再手术率及卒中发生率相当,机械瓣大出血可能性更高。
  • 因生物瓣耐久性有限,尚需更大样本及15年以上随访确定50至69岁同期行AVR+CABG的最佳瓣膜。

研究设计与样本

  • 回顾性队列分析,纳入2002至2018年湖北医院2485例50至69岁行AVR+CABG患者。
  • 中位随访6.5年(四分位距0至15.8年),按18项基线特征倾向评分匹配后生物瓣与机械瓣各346对。

主要发现

  • 两组生存、卒中及总再手术率无差异。

临床怎么用

  • 50至69岁行AVR+CABG选择瓣膜时,应权衡生物瓣再手术风险与机械瓣大出血风险。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The optimal prosthesis for aortic valve replacement (AVR) with concomitant coronary artery bypass grafting (CABG) is controversial. We investigated postoperative outcomes in these patients with a biological prosthesis or mechanical prosthesis. METHODS: A retrospective cohort analysis was performed of 2485 patients aged 50 to 69 years who underwent AVR+CABG in Hubei province hospitals from 2002 to 2018. The median follow-up duration was 6.5 years (interquartile range, 0-15.8 years). Propensity score matching for 18 baseline characteristics yielded 346 patient pairs between bioprosthetic and mechanical prosthetic groups. End points were death, stroke, major bleeding event, and reoperation. RESULTS: No differences in survival, stroke, or overall reoperation rates were observed between the bioprosthetic and mechanical valve groups. The 15-year cumulative incidence of reoperation due to prosthesis failure/dysfunction was higher in the bioprosthetic group (hazard ratio [HR], 2.72; 95% confidence interval [CI], 1.26-5.88; P = .011), whereas the 15-year cumulative incidence of reoperation due to coronary artery disease progression/bypass failure was similar between 2 groups (HR, 0.76; 95% CI, 0.37-1.57; P = .459). Mechanical valves were associated with a higher 15-year cumulative incidence of major bleeding events compared with bioprosthetic valves (HR, 1.92; 95% CI, 1.16-3.19; P = .012). CONCLUSIONS: Long-term survival, overall reoperation, or stroke incidence was comparable among the 2 groups, while patients with a mechanical valve showed a greater likelihood of major bleeding events. Regarding the limited durability of bioprosthetic valves, a larger sample size monitored for 15 or more years will be necessary to determine the optimal aortic valve prosthesis for patients aged 50 to 69 years undergoing concurrent AVR and CABG.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Hu X, Jiang W, Li H, et al. Prosthesis Selection for Aortic Valve Replacement With Concomitant Coronary Artery Bypass Grafting. Ann Thorac Surg. 2021. PMID: 33667456. doi:10.1016/j.athoracsur.2021.02.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。